Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

14:44 ET binx health annonce la prise en charge des premiers patients bénéficiant d'un test et traitement pour la chlamydia et la gonorrhée en une seule visite

binx health, le pionnier des tests de dépistage pour la santé des femmes en tout lieu et à tout moment, a annoncé aujourd'hui la première utilisation ...


12:50 ET ESMO-Jahrestagung 2019: Menarini Ricerche präsentiert die präklinische Charakterisierung von MEN1611, einem neuartigen PI3K-Inhibitor in der Entwicklung zur Behandlung von Brustkrebs

Vielversprechende Ergebnisse der präklinischen Studie von Menarini Ricerche an MEN1611, einem potenten und selektiven, in oral einzunehmender Form...


12:48 ET Congrès annuel 2019 de l'ESMO : Menarini Ricerche présente la caractérisation préclinique de MEN1611, un inhibiteur de la kinase PI3K innovant en cours de développement pour le traitement du cancer du sein

Résultats prometteurs de l'étude préclinique menée par Menarini Ricerche portant sur MEN1611, un inhibiteur de la phosphatidylinositol 3-kinase...


11:52 ET binx health apresenta primeiros pacientes a se beneficiar do teste e tratamento de clamídia e gonorreia em uma única consulta médica

a binx health, pioneira na realização testes em qualquer lugar, a qualquer tempo, em favor da saúde das mulheres, anunciou hoje o uso pela primeira...


11:11 ET Conformal Medical Announces Presentation of US Feasibility Study Data at TCT 2019 in San Francisco

Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Closure (LAAC) System, will present data on the first human implants of its ...


11:00 ET Discontinuing insulin for older adults with type 2 diabetes

Patients with type 2 diabetes who were in poor health were more likely to continue taking insulin after age 75 than their counterparts in better...


10:29 ET Mitsubishi Tanabe Pharma Corporation Group Announces Presentation of Patient-Reported Results from Phase 2 ND0612 Study at International Congress of Parkinson's Disease and Movement Disorders

Mitsubishi Tanabe Pharma Corporation Group announced today the presentation of an analysis of secondary, patient-reported outcomes from a Phase 2...


10:28 ET Erste Patienten profitieren vom Chlamydien- und Gonorrhoe-Soforttest von binx health und der damit verbundenen Behandlung

binx health, Pionier in Sachen Gesundheitstests für Frauen, überall und jederzeit, gab heute die erste praktische Verwendung der binx-io-Plattform...


09:31 ET CenExel Chief Scientific Advisor Todd Bertoch, MD, to Lead Session at Pain Therapeutics Summit 2019

CenExel Clinical Research, Inc., ("CenExel" or the "Company") announced that Todd Bertoch, MD, Chief Scientific Advisor for CenExel and Chief Medical ...


09:26 ET 4D pharma plc: Publicación de los datos de los programas de enfermedades neurodegenerativas

4D pharma plc ("la compañía" o "4D") (AIM: DDDD), una compañía farmacéutica que ha dirigido el desarrollo de Live Biotherapeutics, anunció hoy la...


09:19 ET binx health anuncia a los primeros pacientes que se benefician de una prueba y tratamiento en una sola visita para curar la clamidia y la gonorrea

binx health, el pionero en pruebas de salud para las mujeres en cualquier lugar y en cualquier momento, anunció hoy el primer uso en el mundo real de ...


08:00 ET Phoenix Molecular Designs Receives FDA Clearance to Begin Phase 1/1b Clinical Trial with PMD-026, a First-in-Class RSK Inhibitor, Targeting Advanced Breast Cancer

Phoenix Molecular Designs (PhoenixMD), a clinical stage biotechnology company developing precise cancer therapeutics targeting essential kinases,...


08:00 ET Actinium Announces Iomab-B Poster Selected for Honorable Distinction Award at the 2019 Society of Hematologic Oncology Annual Meeting from Nearly Four Hundred Abstracts

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that a poster highlighting Iomab-B, its pivotal Phase 3 targeted...


08:00 ET Neurana Pharmaceuticals Announces Positive Topline Results from Phase 2 STAR Study of Tolperisone in Acute Muscle Spasms of the Back

Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced positive...


08:00 ET Cardax Announces Interim Results from CHASE Clinical Trial

Cardax, Inc. (OTCQB: CDXI) today announced results from the pre-specified interim review of its ongoing CHASE (Cardiovascular Health Astaxanthin...


08:00 ET ESMO Annual Meeting 2019: Menarini Ricerche Presents the Preclinical Characterization of MEN1611, a Novel PI3K Inhibitor in Development for the Treatment of Breast Cancer

Promising results from the preclinical study conducted by Menarini Ricerche on MEN1611, a potent and selective orally available phosphatidylinositol...


07:30 ET Rigel's fostamatinib Enters Phase 3 Clinical Trial in Japan with Kissei Pharmaceuticals for the Treatment of Chronic Immune Thrombocytopenia

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that its collaboration partner, Kissei Pharmaceuticals Co., Ltd. ("Kissei"), has initiated ...


07:00 ET I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Multiple Cancer Types

I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical stage biopharmaceutical company exclusively focusing on the discovery and development of...


07:00 ET Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that...


06:45 ET Mallinckrodt Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft® Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns

Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced positive top-line results from its pivotal Phase 3 clinical trial...


06:00 ET First MitraClip™ Procedure Performed Using the All-in-One VersaCross™ Transseptal Solution

TORONTO, Sept. 23, 2019 /PRNewswire/ - Baylis Medical announced today the successful first MitraClip™ procedure performed using the VersaCross™...


04:00 ET BioVentrix Announces Study Design for REVIVE-HF: Randomized Controlled Trial (RCT) in Europe

The Revivent TC™ System has continued to deliver impressive results when evaluating post-market data in Europe. The last 35 consecutive cases have...


03:01 ET AbbVie to Present New and Updated Data From 22 Abstracts, Including Two Late-Breaking Abstracts for ABBV-951 and DUODOPA® (levodopa/carbidopa intestinal gel), at the International Congress of Parkinson's Disease and Movement Disorders®

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced experts in the neuroscience field will present results from...


02:00 ET 4D pharma plc: Publication of Data on Neurodegenerative Disease Programmes

4D pharma plc (the "Company" or "4D") (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces the...


02:00 ET New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care

Merck KGaA, Darmstadt, Germany, a leading science and technology company, which operates its biopharmaceutical business as EMD Serono in the US and...